Air Liquide is to expand its home healthcare business in Europe with the announcement that it has acquired Baywater Healthcare Ireland Limited, a major player in this field in Ireland.
The acquisition marks a new geographical development for Air Liquide’s home healthcare business, with the extension of its services to Ireland.
Baywater Healthcare Ireland Limited has 50 employees and cares for 10,000 patients, generating revenue of more than €12m in 2014.
Air Liquide will continue growing the company with the support of the existing team, gasworld understands.
Pascal Vinet, Vice-President, Healthcare Global Operations and member of Air Liquide group’s Executive Committee, said of the deal, “The acquisition of this company, which is recognised for its expertise in the treatment of respiratory diseases and for its culture of innovation, is part of Air Liquide’s growth strategy for the home healthcare business. It will allow us to develop on a new growth market in Europe.”
On the Irish market for 30 years, Baywater Healthcare Ireland Limited specialises in treating and monitoring respiratory diseases in the patient’s home.
Oxygen therapy, continuous positive airway pressure, and non-invasive ventilation are examples of the company’s services.